Clinical Trial Update: A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing OROS oxybutynin to immediate-release Ditropan in patients with urge or mixed urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urge Incontinence
• Urinary Incontinence

Drugs mentioned

• Ditropan (oxybutynin)
• OROS Oxybutynin (oxybutynin)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Urge Incontinence | Phase 3 | Status: COMPLETED